Corindus Vascular Robotics, Inc. (CVRS - Free Report) was a big mover last session, as the company saw its shares rise more than 14% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the company—as the stock is now up 2.4% in the past one-month time frame.
The stock gained after the developer of precision vascular robotics reported that it has obtained PMDA approval for the commercialization of its CorPath GRX System in Japan, which is one of the largest percutaneous coronary interventions (PCI) markets in the world.
The company has seen no changes when it comes to estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter has also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Corindus Vascular Robotics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Medical - Instruments industry may consider Intuitive Surgical, Inc. (ISRG - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Is CVRS going up? Or down? Predict to see what others think:Up or Down
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>